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Abstract
Vascular calcification is a complex process and has been associated with aging, diabetes,
chronic kidney disease (CKD). Although there have been several studies that examine the
role of miRNAs (miRs) in bone osteogenesis, little is known about the role of miRs in vascu-
lar calcification and their role in the pathogenesis of vascular abnormalities. Matrix vesicles
(MV) are known to play in important role in initiating vascular smooth muscle cell (VSMC)
calcification. In the present study, we performed miRNA microarray analysis to identify the
dysregulated miRs between MV and VSMC derived from CKD rats to understand the role of
post-transcriptional regulatory networks governed by these miRNAs in vascular calcification
and to uncover the differential miRNA content of MV. The percentage of miRNA to total
RNA was increased in MV compared to VSMC. Comparison of expression profiles of
miRNA by microarray demonstrated 33 miRs to be differentially expressed with the majority
(~ 57%) of them down-regulated. Target genes controlled by differentially expressed miR-
NAs were identified utilizing two different complementary computational approaches
Miranda and Targetscan to understand the functions and pathways that may be affected
due to the production of MV from calcifying VSMC thereby contributing to the regulation of
genes by miRs. We found several processes including vascular smooth muscle contraction,
response to hypoxia and regulation of muscle cell differentiation to be enriched. Signaling
pathways identified included MAP-kinase and wnt signaling that have previously been
shown to be important in vascular calcification. In conclusion, our results demonstrate that
miRs are concentrated in MV from calcifying VSMC, and that important functions and path-
ways are affected by the miRs dysregulation between calcifying VSMC and the MV they
produce. This suggests that miRs may play a very important regulatory role in vascular cal-
cification in CKD by controlling an extensive network of post-transcriptional targets.
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Introduction
Vascular (arterial) calcification is a prominent finding in aging, diabetes, chronic kidney dis-
ease (CKD), and inflammatory diseases, and is associated with increased morbidity and mor-
tality [1]. The pathophysiology of vascular calcification (also called mineralization) is complex,
but appears to be similar to normal bone osteogenesis. Vascular smooth muscle cells (VSMC)
alter to an osteoblast like phenotype which synthesizes matrix vesicles (MV), 50–200 nm
spheres that contain calcium and phosphate and initiate mineralization within the extracellular
matrix. MVs are present by electron microscopy in normally calcified tissues such as bone and
cartilage and in aberrant calcification sites such as vascular calcification. These osteoblast like
cells also secrete the extracellular matrix (ECM) proteins on which MVs initiate mineralization
[2, 3]. The protein content of MV appears to be a central determinant of the ability to mineral-
ize the ECM. We have previously demonstrated that MV with increased annexin II and VI and
minimal fetuin-A content can mineralize on an ECM, but MV with decreased content of
annexin II and VI and increased fetuin-A do not [4].
Matrix vesicles are similar to microparticles and exosomes, and studies have demonstrated
the ability of these other vesicle like structures from non-mineralizing cells to transfer RNA or
microRNA (miRNA) to new cells [5] facilitating cell to cell or cell to extracellular matrix com-
munication. MiRNA are fragments of noncoding RNA typically ~22 nucleotides in length that
negatively regulate protein-coding genes by acting as posttranscriptional repressors of gene
expression. MicroRNAs suppress gene expression via imperfect base pairing to the 3’ untrans-
lated region (3’UTR) of target mRNAs leading to repression of protein production or mRNA
degradation. Accumulating evidence indicates that miRNA’s play a crucial role in regulating
various cellular processes by controlling the expression of vast number of genes post-
transcriptionally [6]. Importantly, a single miRNA may affect transcription of multiple genes
involved in common pathways.
Computational methods have played an important role in the prediction of miRNA targets
from the very beginning. Traditionally, some major features such as hairpin-shaped stem loop
structure, high minimal folding free-energy, gene expression relationships between miRNA-
mRNA pairs and high evolutionary conservation of the seed regions have been used in the
computational identification of targets [6]. In this study, we have therefore employed two dif-
ferent complementary computational approaches which employ these features, namely
Miranda [4] and Targetscan [7] to predict the mRNA targets of the differentially expressed
miRNAs. In the current study, we aimed to understand the differentially present miRNA in cal-
cifying VSMC (incubated with high phosphorus media) and the MV they produce. We used
miRNA array and bioinformatics analyses to identify dysregulated miRNA in CKD animals
that may provide insight into the cellular regulation of MV packaging of miRNA and to deter-
mine what post-transcriptional networks are involved as VSMC initiate calcification.
Materials and Methods
Animal models and cell culture
Primary rat vascular smooth muscle cells (VSMC) were isolated from our rodent model of
Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD), the Cy/+ rat model cystic kid-
ney disease (CKD rat). This model spontaneously develops all three manifestations of
CKD-MBD: biochemical abnormalities, extraskeletal calcification, and abnormal bone [8].
Briefly, VSMC were isolated from the descending thoracic aorta in CKD rats (age 35 week old)
by the explant method as previously described [7] and grown in Dulbecco’s Modified Eagles
Medium (DMEM; Sigma, St. Louis, MO), with 10% FBS. To induce calcification, VSMC were
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treated with 5 mmol/L β-glycerophosphate, 1 U/ml fetal alkaline phosphatase, 10-7 mol/L insu-
lin and 50 μg/ml ascorbic acid in the presence of 15% serum [9]. The β-glycerophosphate is
cleaved by the alkaline phosphatase to release phosphorus and thus this approach allows
VSMC to be incubated in high phosphorus media without concerns of spontaneous precipita-
tion. Such high phosphorus “calcifying”media induced the de-differentiation needed for
VSMC to calcify in vitro [4, 9]. All procedures were reviewed and approved by the Indiana
University School of Medicine Institutional Animal Care and Use Committee.
Matrix vesicle (MV) isolation
MV were isolated from calcifying VSMC obtained from three CKD rats by collagenase diges-
tion as previously described [4]. Calcifying VSMC were incubated with crude collagenase
(500 U/ml, type IA, Sigma) in a solution of 0.25 M sucrose, 0.12 M NaCl, 0.01 M KCL and
0.02 M Tris buffer, pH 7.45, at 37°C for 3 hrs. The digests were centrifuged at 800 g and 30,000
g to remove cell debris and microsomes, respectively. The supernatant was centrifuged at
250,000 g to pellet the MV followed by resuspension in TBS (pH 7.6) with 0.25 M sucrose. The
MV amount was determined by protein concentration (Bio-Rad). We used 3 different CKD
rats to isolate 3 different VSMC cultures. Each of these three cultures was used to isolated MV.
We then ran separate arrays on each of the VSMC-MV pairs.
RNA isolation, quantification and micro-RNA array
Total RNA from VSMC or MV was isolated using miRNeasy Mini Kit (Qiagen) according to
the manufacturer’s instructions. Total RNA was eluted from the column in RNase-free water
and stored at -80°C. Quantification of miRNA was performed at the Center for Genetics in
Indiana University School of Medicine using Agilent 2100 Bioanalyzer Small RNA kit.
To perform the arrays, total RNA samples were labeled using the Genisphere FlashTag HSR
kit. The labeled samples were individually hybridized to Affymetrix GeneChip miRNA 3.0
arrays. They were stained and washed using the standard miRNA protocol. Affymetrix Gene-
Chip Command Console Software (AGCC) was used to scan the arrays and generate CEL files.
CEL files were imported into Partek Genomics Suite (Partek, Inc., St. Louis, Mo). RMA (robust
multi-array average) signals were generated for all probe sets using the RMA background cor-
rection, quantile normalization and summarization by Median Polish [10]. Summarized sig-
nals for each probe set were log2 transformed. These log transformed signals were used for
Principal Components Analysis, hierarchical clustering and signal histograms to determine if
there were any outlier arrays. No outliers were detected in this analysis. Untransformed RMA
signals were used for fold change calculations. Contrasts were calculated as required. Fold
changes were calculated using the untransformed RMA signals. Probe sets with log2 expression
levels< 1.0 were considered very close to background. Probe sets with average expression
levels< 1.0 were removed before the False Discovery Rate (FDR) was calculated using the Sto-
rey method [11].
Identification of dysregulated miRNAs in MV vs VSMC in CKD rats
The sequence of analyses performed in this study was shown in flowchart in Fig 1. We had a
dataset of 680 rat miRNA’s profiled experimentally in the chronic kidney disease rats in both
Matrix Vesicles (MV) and Vascular Smooth Muscle Cells (VSMC). Their expression change
was measured in terms of fold change in expression from MV to VSMC in these CKD rats. We
used highly stringent thresholds of p-value< = 0.001, FDR = 5% to obtain a set of dysregulated
miRs between these two conditions.
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Target prediction for miRNAs
For predicting miRNA targets in the rat genome, we used two different approaches which
employ complementary criteria, in order to obtain highest prediction power and reliability.
These methods included 1) Miranda, which is a machine learning method for ranking micro-
RNA target sites by a down-regulation score by integrating gene expression and sequence level
features. The algorithm trains a regression model on sequence and contextual features
extracted from high confidence miRanda-predicted target sites and hence can predict non-
canonical and non-conserved sites producing complementary predictive power to other exist-
ing approaches [12] and 2) Targetscan: predicts targets for miRNA’s using context scores
based on the extent of conservation of the seed region in the target mRNAs 3’UTR across vari-
ous mammalian orthologs [13]. For Miranda, we obtained 3’UTR fasta sequence file from bio-
mart-ensembl (http://www.ensembl.org/biomart/martview) for the rat genome and used it as
the input. For Targetscan, we used the 3’UTR multiple sequence alignment file available from
the target scan database for rattus norvegicus. To predict the mRNA targets for the set of
Fig 1. Flowchart showing the various steps involved in this study. Flowchart summarizing the sequence of analyses performed in this study.
doi:10.1371/journal.pone.0131589.g001
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dysregulated miRs, for Miranda we used score(S)> 150 and free energy (ΔG)< -22kcal/mol as
the thresholds while for Targetscan we used context+score -0.3 for identifying genes post-
transcriptionally controlled by the miRs. Complete set of targets predicted by both the methods
for the dysregulated miRs are shown in S1 Table.
Constructing high-confidence post-transcriptional regulatory network of
dysregulated miRs
Most microRNAs control the expression of hundreds of target transcripts in a cell, typically by
base-pairing with the 3’ untranslated regions, resulting in a global post-transcriptional regula-
tory network [6]. To construct a high-confidence post-transcriptional regulatory network of
miRNAs which are dysregulated between VSMC and MV in CKD rats, we first identified the
target transcripts of miRNAs using two different well-established computational methods for
miRNA target prediction, namely Miranda and Targetscan, as described above. Resulting pre-
dictions were then filtered to include only those mRNAs identified as targets of each miRNA,
by both the computational methods—referred to as the intersection approach, thus allowing
the construction of a high confidence network. In other words, we used predictions from
Miranda and TargetScan and confirmed a target for miR only if it is predicted by both the
methods at default thresholds. Using this approach we constructed a network of miR and its
targets for all dysregulated miRs. Though this approach reduces the number of targets for
miRs, it ensures to generate a robust set of miR targets allowing the analysis and interpretation
of the miRNA controlling network in vascular calcification.
Constructing a network of genes controlled by multiple miRs
We obtained the genes which are controlled by at least 3 dysregulated miRs and then grouped
these networks into two sections 1) Genes controlled by at least 3 miRs which are enriched in
MV compared to VSMC and 2) Genes controlled by at least 3 depleted miRs in MV compared
to VSMC. Both of these networks were derived from high-confidence network constructed in
the previous step. Further, we performed functional enrichment of genes in these networks to
identify the pathways and functions affected due to the dysregulation of miRNAs.
Functional enrichment of genes controlled by multiple miRs
Since miRNA-mediated gene expression change can contribute to functional and phenotypic
consequences, we identified the genes controlled by at least 3 dysregulated miRNAs to uncover
the functions and pathways which are affected due to their dysregulation. Genes which were
controlled by at least 3 miRs were used for functional enrichment analysis using ClueGO—a
plugin in cytoscape which helps in the visualization of the enriched biological functions in
terms of a network [14]. We also used David [15, 16] a functional/pathway enrichment tool to
independently compare our functional analysis results. This analysis allowed us to predict the
pathways and functions which are likely disrupted or altered due to variations in the regulation
at post-transcriptional level by miRs.
Assignment of functional roles to miRs
We also obtained enriched functions in the targets predicted to be controlled by miRs, by per-
forming a functional enrichment of the genes controlled by miRs individually. We used David
[15, 16] to extract enriched functions for each miR. All the functions obtained were filtered at
p-value< = 0.01 (FDR< 5%) and only those miRs which had at least one significant function
are shown in Table 1.
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Table 1. Enriched functions associated with dysregulated miRs based on the functional enrichment of the predicted targets.
miR Enriched Functions Supporting
Publications
rno-miR-299_st (#) phosphoprotein NA
rno-miR-30e_st (#) prenylation, mutagenesis site [24]
rno-let-7b_st (#) GO:0000166~nucleotide binding, GO:0001882~nucleoside binding NA
rno-miR-24_st (#) phosphoprotein, GO:0046983~protein dimerization activity, GO:0008610~lipid biosynthetic process [28]
rno-miR-99b_st (#) Malaria NA
rno-miR-324-3p_st
(#)
phosphotransferase, GO:0030005~cellular di-, tri-valent inorganic cation homeostasis,
GO:0007243~protein kinase cascade, alternative splicing, GO:0006468~protein amino acid
phosphorylation, GO:0001754~eye photoreceptor cell differentiation, GO:0007242~intracellular signaling
cascade
NA
rno-miR-19b_st (#) phosphoprotein, GO:0006163~purine nucleotide metabolic process, alternative splicing,
GO:0007264~small GTPase mediated signal transduction, prenylation, GO:0006164~purine nucleotide
biosynthetic process
NA
rno-miR-423_st (#) nucleotide-binding, GO:0007242~intracellular signaling cascade NA
rno-miR-106b-
star_st (#)
GO:0007264~small GTPase mediated signal transduction, IPR005225:Small GTP-binding protein NA
rno-miR-99b-star_st
(#)
mutagenesis site NA
rno-miR-30d_st (#) prenylation [24]
rno-miR-27a-star_st
(#)
GO:0007242~intracellular signaling cascade [29]
rno-miR-199a-5p_st
(#)
Signal-anchor, phosphoprotein, GO:0006631~fatty acid metabolic process, IPR018503:Tetraspanin,
conserved site
NA
rno-miR-181b_st (#) GO:0010608~posttranscriptional regulation of gene expression [30]
rno-miR-92b-star_st
(")
GO:0043009~chordate embryonic development, GO:0006814~sodium ion transport,
GO:0044057~regulation of system process
[31]
rno-miR-3568_st (") GO:0007188~G-protein signaling, coupled to cAMP nucleotide second messenger NA
rno-miR-667-star_st
(")
alternative splicing, GO:0016192~vesicle-mediated transport, GO:0007158~neuron adhesion NA
rno-miR-204-star_st
(")
GO:0032268~regulation of cellular protein metabolic process, GO:0006468~protein amino acid
phosphorylation, GO:0008284~positive regulation of cell proliferation, GO:0010604~positive regulation of
macromolecule metabolic process, GO:0044093~positive regulation of molecular function,
GO:0005343~organic acid:sodium symporter activity
[27]
rno-miR-1224_st (") cell cycle control, hsa04310:Wnt signaling pathway NA
rno-miR-181d-
star_st (")
GO:0008289~lipid binding, GO:0006811~ion transport [30]
rno-miR-3562_st (") GO:0048640~negative regulation of developmental growth, GO:0010324~membrane invagination,
GO:0006897~endocytosis, GO:0022898~regulation of transmembrane transporter activity,
GO:0016192~vesicle-mediated transport, GO:0006811~ion transport, GO:0010608~posttranscriptional
regulation of gene expression
NA
rno-miR-3584-5p_st
(")
mutagenesis site, GO:0001609~adenosine receptor activity, G-protein coupled, GO:0010604~positive
regulation of macromolecule metabolic process, alternative splicing
NA
rno-miR-702-5p_st
(")
disease mutation NA
rno-miR-296_st (") hsa04270:Vascular smooth muscle contraction NA
rno-miR-770-star_st
(")
nucleotide-binding NA
rno-miR-150-star_st
(")
GO:0004842~ubiquitin-protein ligase activity, GO:0043632~modiﬁcation-dependent macromolecule
catabolic process,
NA
(Continued)
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Confirmation by real-time PCR
We then confirmed miRNA expression of selected miRNA that controlled multiple genes and/
or controlled pathways which are known to be important in vascular calcification, by real time
PCR as previously described [17] using TaqMan miRNA assays (Applied Biosystems, Foster
City, CA). Forty ng of total RNA were used for reverse transcription to synthesize complemen-
tary DNA using TaqMan miRNA-specific primers and the Taq reverse transcription kit
(Applied Biosystems, Foster City, CA). Target-specific PCR primers (miR-667, miR-702, miR-
3562, miR-3568 and miR-3584) were obtained from Applied Biosystems. Real-time PCR
amplifications were performed using TaqMan miRNA Assays (TaqMan MGP probes, FAM
dye-labeled) using Applied Biosystems 7500 Real-Time PCR systems (Applied Biosystems).
The cycle number at which the amplification plot crosses the threshold was calculated (CT),
and the ΔΔCT method was used to analyze the relative changes in gene expression and normal-
ized by U6, a non-human ubiquitous miRNA.
Results
MV contains greater amount of miRNA but less total RNA compared to
VSMC
To determine the total RNA and miRNA concentration in MV compared to VSMC which they
are originated, total RNA was isolated fromMV and VSMC and the relative concentrations of
total RNA and miRNA determined by Agilent 2100 Bioanalyzer total RNA and Small RNA
kits, respectively. The results demonstrated that total RNA concentration is 4 times greater in
VSMC than that in MV (Fig 2A). In contrast, percent of miRNA of total RNA in MV is 4 times
greater than that in VSMC (Fig 2B), confirming that miRNA are concentrated in MV as they
are in exosomes.
Several genes were found to be controlled by dysregulated miRs
Micro RNA array demonstrated that 14 miRNAs increased by 2 fold or more (defined as
enriched set of miRNAs) and 19 miRNA decreased at least by 2 fold or more (depleted set) in
MV compared to the calcifying VSMC from which they originate using the high stringency cri-
teria (Fig 3). By both the computational methods (Miranda and Targetscan) we demonstrated
that in the enriched set, miR-328a-star_st was found to control maximum number of targets
(381) followed by miR-3562 controlling 341 putative targets. In the set of depleted miRs, we
found miR-24 to control 262 target mRNAs followed by miR-324-3p which controlled 215 tar-
gets. We generated network visualizations showing the network for the two sets of miRs
Table 1. (Continued)
miR Enriched Functions Supporting
Publications
rno-miR-328a-
star_st (")
GO:0030182~neuron differentiation, GO:0004672~protein kinase activity, GO:0016486~peptide hormone
processing, GO:0031668~cellular response to extracellular stimulus, GO:0006915~apoptosis,
GO:0014070~response to organic cyclic substance, GO:0031012~extracellular matrix,
GO:0009967~positive regulation of signal transduction, GO:0008284~positive regulation of cell
proliferation, GO:0035270~endocrine system development, GO:0010647~positive regulation of cell
communication, GO:0048168~regulation of neuronal synaptic plasticity
NA
All the functions shown are signiﬁcant at p-value < = 0.01. MicroRNAs whose levels are higher in MV compared VSMC are highlighted with an upward
arrow (") in the ﬁrst column, while those which were found to occur in lower levels in MV are sufﬁxed with a downward arrow (#).
doi:10.1371/journal.pone.0131589.t001
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controlling their targets using Cytoscape [18]. Fig 4 shows a network comprising of 2572 edges
with all their enriched miRs and their controlled target genes. Similarly, a total of 1933 edges
comprising of 19 depleted miRs and predicted targets are shown in Fig 5. As is evident from
the figure miRs 328a, 3584, 667 and 3562 were found to control a large number of targets
among the enriched set of miRs while the dominant players in the depleted set included miRs
24, 199a-5p, 324-3p and 19b. Further, we obtained genes which are controlled by at-least 3
miRs either enriched or depleted. This resulted in a set of 235 genes to be controlled by at least
3 miRs. Table 1 shows the list of all the dysregulated miRs for which functions and processes
they control could be confidently predicted (p-value< = 0.01). Functional enrichment was
performed using David and all the functions obtained at p-value< = 0.01 and top 25% are dis-
played (For extended information see S2 Table).
Fig 2. miRNA is concentrated in MV compared to VSMC fromCKD rats. Total RNA from VSMC or MV was isolated from CKD rats and quantification
performed using Agilent 2100 Bioanalyzer total and Small RNA kit. The results demonstrated that the total RNA level (A) is greater but miRNA levels are
lower in VSMC compared to MV (B). n = 3, Data were expressed as mean±SEM, *p<0.05, MV vs. VSMC.
doi:10.1371/journal.pone.0131589.g002
Role of miRNA Expression in VSMC and MV
PLOSONE | DOI:10.1371/journal.pone.0131589 June 26, 2015 8 / 16
Functional and pathway enrichment of genes controlled by multiple miRs
We performed functional and pathway enrichment for the genes controlled by at least 3 miRs
using ClueGo—a plugin in Cytoscape [14] and David—a functional/pathway enrichment tool
[15, 16]. We obtained orthologs of genes controlled by at least 3 miRs in mouse as ClueGo is
not capable of handling the rat genome and visualized the network of functions obtained at
p-value< = 0.05 (Fig 6). Further, we also performed functional and pathway enrichment of
the genes using David with the background species set to rat (rattus novergicus) at a p-value
< = 0.01 and FDR = 5% (see S1 Fig and S3 Table). The results demonstrated several important
pathways and functions to be associated with the genes controlled by multiple dysregulated
miRs between VSMC and MV.
PCR Validation of miRNA expression pattern in MV and VSMC
Our microarray analysis and target prediction using computational methods for the 33 miR-
NAs revealed that the representative set of miRs: miR-667, miR-702, miR-3562, miR-3568 and
miR-3584 either controlled genes of interest in the formation of MV, or were predicted to tar-
get many genes, with significantly higher expression in MV compared to VSMC from microar-
ray data analysis (Table 1 & Fig 3). Hence, to confirm the expression of these miRNA in MV
and VSMC, we performed the real time PCR. The results demonstrated that miR-667, miR-
702, miR-3562, miR-3568 and miR-3584 are all expressed in VMSC from CKD rats and are
highly concentrated in MV, confirming directional changes from microarray analysis (Fig 7).
Fig 3. The fold change in expression of 33 miRs dysregulated in MV compared to VSMC fromCKD rats. All the 33 miRs were filtered at p-value < =
0.001 and FDR = 5% and isolated from 3 different rats Blue color represents the up-regulated miRs whereas the orange color represents the down-regulated
miRs.
doi:10.1371/journal.pone.0131589.g003
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Discussion
VSMC exposed to high levels of phosphorus make MV that calcify an extracellular matrix more
than cells not exposed to high phosphorus [4]. In the present study, we compared the expression
profiles of VSMC compared to MV from calcifying CKD VSMC cells to identify potential regu-
latory pathways controlled by miRNAs via the production of MV from calcifying VSMC. As
shown in Fig 2, there are 14 miRNAs increased by 2 fold or more and 19 miRNA decreased at
least by 2 fold or more in MV compared to VSMC. The arrays were run fromMV isolated from
VSMC from three different CKD rats, with stringent criteria for selection and thus these
miRNA were consistently found altered in MV. These results suggest that the miRNA expres-
sion profiles are different in MV compared to the cells from which they originate. Accumulating
evidence indicates that miRNA’s play a crucial role in regulating various cellular processes by
controlling the expression of vast number of genes post-transcriptionally. MicroRNAs play a
critical function during development through effects on cell proliferation, differentiation, and
apoptosis [19, 20]. In adults, abnormalities in miRNA expression have been identified in multi-
ple diseases including malignancies, inflammatory and cardiovascular diseases [19, 21].
Several genes can be controlled by multiple miRNAs. To understand the network of
miRNA-mRNA associations formed by these miRNAs which are dysregulated, we constructed
such a high confident network by including genes which are controlled by multiple dysregu-
lated miRs. We performed functional enrichment of the genes controlled by individual dysre-
gulated miRs to obtain enriched functions for miRs. This enabled the identification and
Fig 4. Network of up-regulated miRs and the targets (genes) controlled by them. Red/orange nodes represent miRNA, with number corresponding to
the table; the larger the node the more genes targeted. The green/yellow nodes represent genes regulated by these miRNA and the black lines the
connectivity between miRNa and target genese. The highest degree which was observed to be 381 targets in this network. Network is generated using
Cytoscape.
doi:10.1371/journal.pone.0131589.g004
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association of most dysregulated miRs with specific functions they are most likely to effect. Sev-
eral of the predicted functions and processes for these miRs had prior support for their func-
tional roles as is evident from the related citations shown in the table, whereas other pathways
had not previously been associated with calcification or exosome production. Key pathways
identified include vascular smooth muscle contraction, positive regulation of muscle differenti-
ation, and response to hypoxia. The latter included miRNA that regulate vascular endothelial
growth factor (VEGF) a critical regulator of vascular smooth muscle cell function [22]. Our
group recently found that VEGF expression may be an indicator of de-differentiation from
VSMC cells to osteoblast like cells (unpublished data). Assessment of cell signaling pathways
indicated calcium and MAPK signaling pathways to be over-represented in the gene set con-
trolled by dysregulated miRs, MAPK signaling has been shown to be involved in calcification
of VMSC [23], but direct confirmation that these miRNA are involved in calcium and MAPK
signaling of calcification will require further studies.
Previous studies have shown that miR-30 family members negatively regulate osteoblast dif-
ferentiation [24] and also suggest RUNX2 and SMAD1 are common post-transcriptional targets
of miR-30 family. Our results support and reinforce these observations. Indeed, our high confi-
dence network suggests that RUNX2 is controlled by miR-30d as well as miR-30e and both of
these miRs are down-regulated which suggests that they play a major role in regulating osteo-
blast differentiation. Another recent study suggested that down-regulation of miR-30 family
leads to endoplasmic reticulum stress in vascular smooth muscle cells [25] and a similar trend
of down-regulation is shown in the case of miR-30d and miR-30e. We also find that ‘response
Fig 5. Network of down-regulatedmiRs and the targets (genes) controlled by them. Color transition of the nodes is based on the degree (number of
connections) of the nodes. Here nodes comprise both miRs and their targets. A table in the figure provides information about the nodes corresponding to the
miRs. 0 represents lowest degree that is 1 and 1 corresponds to highest degree which was observed to be 262 targets in this network. Red color corresponds
to the highest degree and green color corresponds to lowest degree. Network is generated using cytoscape.
doi:10.1371/journal.pone.0131589.g005
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to oxidative stress’was an enriched pathway reinforcing previous observations that oxidative stress
may be involved in both VSMC function and in vascular calcification[26]. In another study by
Cui et. al [27], miR-204 has been shown to be involved in regulating vascular smooth muscle
cell calcification both in-vivo and in-vitro and our analysis found miR-204 to be up-regulated
and controlling several genes which were enriched for regulation of metabolic processes, phos-
phorylation and cell proliferation. Thus, our results confirm the identification of several miR-
NAs which were identified in previous studies to be associated with vascular calcification.
Our study also allowed us to uncover several novel miRNAs which have not previously been
associated with vascular calcification and/or MV formation. Our results also showed enriched
levels of mir-667, mir-702, mir-3562 and mir-3584 as confirmed by RT-PCR data (Fig 7) in
MV compared to VSMC. Functional enrichment analysis of these miRs are listed in Table 1
and S2 Table. We confirmed mir-3568, as it was found to be several fold higher in MV com-
pared to VSMC; functional analysis of its ~70 targets revealed enrichment for genes associated
with G-protein signaling coupled to cyclic AMP nucleotide second messenger. We examined
miR-328a as it also targets many genes that regulate cellular response to extracellular stimulus,
extracellular matrix regulation, apoptosis, positive regulation of cell proliferation, and peptide
hormone processing. We have previously demonstrated that calcifying MV preferentially min-
eralize type I, as opposed to type II collagen [4] and thus miRNA involved in extracellular col-
lagen may be important. We also confirmed mir-667 and miR-3562, as these miRNA
controlled several genes associated with vesicle-mediated transport and thus may play a role in
the formation of MV. The importance of these various pathways in the formation of MV in
Fig 6. Enrichment of biological functions in the gene set controlled by at least 3 miRs using ClueGo. Analyses of those genese controlled by at least
three miRNA were performed to identify important pathways. The genes were categorized based on ClueGo, a plugin of the cytoscape and all the functions
reported are at p-value < = 0.05. The size of the nodes represents the number of miRNAs that regulate the genes, and the connectivity of multiple miRNAs
regulating multiple genes within a common pathway are shown by the black lines. Purine biosynthesis and cAMP regulation demonstrated the most miRNA
regulation (purple nodes).
doi:10.1371/journal.pone.0131589.g006
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vascular calcification have not previously been identified and additional validation studies are
required. These examples illustrate the power of bioinformatics to identify potential novel
pathways. Limitations of the study include the relatively small number of CKD rats studied
(n = 3), and the unknown heterogeneity among the rats. Finally, it is unclear if the miRNA
results from the CKD rat model accurately reflect miRNA changes in humans with CKD,
although miRNA are often evolutionarily conserved. In summary, this study utilized bioinfor-
matics to perform target prediction for dysregulated miRs in MV compared to calcifying CKD
VSMC from which they originated. The resulting networks may help unravel the regulatory
mechanisms by which miRNA may control vascular calcification via MV released from VSMC.
We focused on the complementarity of the target prediction methods, and were very stringent
in constructing the network of miRs and their targets. When two different methods predict the
same target to be controlled by the miR then it not only validates but helps in reproducibility of
results using sub-sampling approach. The identified networks and regulating miRNA provide
useful targets for subsequent confirmation studies that may provide novel targets to impede
the calcification process in VSMC.
Supporting Information
S1 Fig. Bar-chart representing all the functions enriched for the genes controlled by at-least
3 miRs. This bar-chart provides information on the functions and the number of genes for
which the function was enriched at p-value< = 0.05.
(PDF)
Fig 7. RT-PCR validation of selectedmiRNAs n MV and VSMC. To validate the miRNA identified by the arrays that regulate multiple genes, we performed
Real time PCR on VSMc and MV to determine the expression of miR-667, miR-702, miR-3562, mir-3568 and miR-3584 and normalized by U6. Each sample
(n = 3 with MV and VSMC isolated from 3 CKD rats, same samples as arrays) was assayed in triplicate. The results demonstrated increased expression in
MV compared to VSMC for each of these miRNAs, confirming the array results. Data were expressed as mean ± SEM. * p<0.05, MV vs. VSMC.
doi:10.1371/journal.pone.0131589.g007
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S1 Table. High confidence predictions of targets for miRs.Miranda and Target scan were
used to predict targets for miRs and then high confidence table was designed keeping targets
for miRs when predicted by both the methods. Red color represents up-regulated miRs and
blue color represents down-regulated miRs.
(XLSX)
S2 Table. Top 25% enriched functions of miRs both up-regulated and down-regulated.
David was deployed to obtain enriched functions for the genes. All the functions/pathways are
enriched at p-value < = 0.01. Blue tab represents down-regulated miR while red tab represents
up-regulated miR.
(XLSX)
S3 Table. Enriched functions/Pathways for genes controlled by at-least 3 miRs. David was
deployed to obtain enriched functions for the genes. All the functions/pathways are enriched at
p-value< = 0.01 and FDR = 5%.
(XLSX)
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